134 related articles for article (PubMed ID: 11903369)
1. Circulating angiogenic cytokines as tumour markers and prognostic factors in head and neck squamous cell carcinoma.
Homer JJ; Greenman J; Stafford ND
Clin Otolaryngol Allied Sci; 2002 Feb; 27(1):32-7. PubMed ID: 11903369
[TBL] [Abstract][Full Text] [Related]
2. Serum endostatin levels are elevated in patients with soft tissue sarcoma.
Feldman AL; Pak H; Yang JC; Alexander HR; Libutti SK
Cancer; 2001 Apr; 91(8):1525-9. PubMed ID: 11301401
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic cytokines in serum and plasma of patients with head and neck squamous cell carcimona.
Homer JJ; Greenman J; Stafford ND
Clin Otolaryngol Allied Sci; 2000 Dec; 25(6):570-6. PubMed ID: 11123175
[TBL] [Abstract][Full Text] [Related]
4. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.
Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M
Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of angiogenin, basic fibroblast growth factor and endostatin in patients receiving intensive chemotherapy for acute myelogenous leukemia.
Glenjen N; Mosevoll KA; Bruserud Ø
Int J Cancer; 2002 Sep; 101(1):86-94. PubMed ID: 12209593
[TBL] [Abstract][Full Text] [Related]
6. Arterial Hypertension Is Characterized by Imbalance of Pro-Angiogenic versus Anti-Angiogenic Factors.
Marek-Trzonkowska N; Kwieczyńska A; Reiwer-Gostomska M; Koliński T; Molisz A; Siebert J
PLoS One; 2015; 10(5):e0126190. PubMed ID: 25951297
[TBL] [Abstract][Full Text] [Related]
7. Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression.
Kurschat P; Eming S; Nashan D; Krieg T; Mauch C
Br J Dermatol; 2007 Apr; 156(4):653-8. PubMed ID: 17263813
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the angiogenic factors angiogenin, endoglin and endostatin in cervical cancer.
Landt S; Mordelt K; Schwidde I; Barinoff J; Korlach S; Stöblen F; Lichtenegger W; Sehouli J; Kümmel S
Anticancer Res; 2011 Aug; 31(8):2651-5. PubMed ID: 21778318
[TBL] [Abstract][Full Text] [Related]
9. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Lupus; 2002; 11(6):348-55. PubMed ID: 12139372
[TBL] [Abstract][Full Text] [Related]
10. Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia.
Gora-Tybor J; Blonski JZ; Robak T
Mediators Inflamm; 2003 Jun; 12(3):167-71. PubMed ID: 12857600
[TBL] [Abstract][Full Text] [Related]
11. Circulating angiogenesis regulators in cancer patients.
Kuroi K; Toi M
Int J Biol Markers; 2001; 16(1):5-26. PubMed ID: 11288955
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapy.
Dietz A; Rudat V; Conradt C; Weidauer H; Ho A; Moehler T
Head Neck; 2000 Oct; 22(7):666-73. PubMed ID: 11002321
[TBL] [Abstract][Full Text] [Related]
13. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma.
Feldman AL; Alexander HR; Yang JC; Linehan WM; Eyler RA; Miller MS; Steinberg SM; Libutti SK
Cancer; 2002 Oct; 95(8):1637-43. PubMed ID: 12365010
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of circulating angiogenic markers in prostate-specific antigen (PSA)-stable and PSA-progressive hormone-sensitive advanced prostate cancer.
Kohli M; Kaushal V; Spencer HJ; Mehta P
Urology; 2003 Apr; 61(4):765-9. PubMed ID: 12670562
[TBL] [Abstract][Full Text] [Related]
15. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma.
Dhar DK; Ono T; Yamanoi A; Soda Y; Yamaguchi E; Rahman MA; Kohno H; Nagasue N
Cancer; 2002 Nov; 95(10):2188-95. PubMed ID: 12412173
[TBL] [Abstract][Full Text] [Related]
16. Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival.
Dudek AZ; Mahaseth H
Cancer Invest; 2005; 23(3):193-200. PubMed ID: 15945504
[TBL] [Abstract][Full Text] [Related]
17. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.
Ugurel S; Rappl G; Tilgen W; Reinhold U
J Clin Oncol; 2001 Jan; 19(2):577-83. PubMed ID: 11208853
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma.
Sharma BK; Srinivasan R; Kapil S; Singla B; Saini N; Chawla YK; Chakraborti A; Duseja A; Kalra N; Dhiman RK
Mol Cell Biochem; 2013 Nov; 383(1-2):103-12. PubMed ID: 23912396
[TBL] [Abstract][Full Text] [Related]
19. A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases.
Feldman AL; Alexander HR; Bartlett DL; Kranda KC; Miller MS; Costouros NG; Choyke PL; Libutti SK
Ann Surg Oncol; 2001 Oct; 8(9):741-5. PubMed ID: 11597016
[TBL] [Abstract][Full Text] [Related]
20. Indications for postoperative radiotherapy in laryngeal carcinoma: a panel of tumor tissue markers for predicting locoregional recurrence in surgically treated carcinoma. A pilot study.
Marioni G; Blandamura S; Lionello M; Giacomelli L; Lovato A; Favaretto N; Breda S; Tealdo G; Guzzardo V; Ottaviano G; Staffieri A
Head Neck; 2014 Nov; 36(11):1534-40. PubMed ID: 23996283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
